Compounds > arginine

arginine and Granulocytic Leukemia, Chronic

arginine has been researched along with Granulocytic Leukemia, Chronic in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (11.11)	18.7374
1990's	2 (22.22)	18.2507
2000's	3 (33.33)	29.6817
2010's	2 (22.22)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Brabcova, Z; Cheng, P; Copland, M; Dunn, K; Helgason, GV; Ianniciello, A; Kalkman, ER; Mussai, F; Prasad, B; Rattigan, KM; Sarnello, D; Scott, MT; Shokry, E; Sumpton, D; Tardito, S; Vande Voorde, J; Zarou, MM; Zerbst, D	1
Chan, ZE; Chuah, C; Lee, KL; Lee, LM; Majeed, A; Manjeri, A; Ng, KP; Ong, ST; Suda, T; Tan, CY; Tan, QD	1
Camelo-Santos, J; de Paula Silveira-Lacerda, E; do Prado Barbosa, A; Guillo, LA	1
Cobbold, M; Craddock, C; Dafforn, TR; Engelhard, VH; Mahendra, P; Mohammed, F; Moss, PA; Nicholls, S; Piper, KP; Salim, M; Schild, H; Tenzer, S; van Endert, P; Willcox, BE	1
Corbin, AS; Crossman, LC; Deininger, MW; Druker, BJ; Heinrich, MC; Lange, T; Middleton, PG; O'Brien, SG; O'Hare, T; Stoffregen, EP; Willis, SG	1
Adamsky, K; Amariglio, N; Ashur-Fabian, O; Cohen, Y; Hardan, I; Nagler, A; Raanani, P; Rechavi, G; Trakhtenbrot, L	1
Foss, FM; Koc, Y; Urbano, A	1
Constantinou, A; Grdina, D; Huberman, E; Kiguchi, K	1
Dahl, GV; Grier, HE; Kalwinsky, DK; Mason, C; Mirro, J; Murphy, SB; Santana, VM	1

Other Studies

9 other study(ies) available for arginine and Granulocytic Leukemia, Chronic

Article	Year
Arginine dependency is a therapeutically exploitable vulnerability in chronic myeloid leukaemic stem cells. EMBO reports, 2023, 10-09, Volume: 24, Issue:10 Topics: Apoptosis; Arginine; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplastic Stem Cells; Stem Cells	2023
The arginase inhibitor Nω-hydroxy-nor-arginine (nor-NOHA) induces apoptosis in leukemic cells specifically under hypoxic conditions but CRISPR/Cas9 excludes arginase 2 (ARG2) as the functional target. PloS one, 2018, Volume: 13, Issue:10 Topics: Antineoplastic Agents; Apoptosis; Arginase; Arginine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; CRISPR-Cas Systems; Drug Screening Assays, Antitumor; Enzyme Assays; Feasibility Studies; Gene Knockout Techniques; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Primary Cell Culture; RNA, Small Interfering	2018
Arginine homozygosity in codon 72 of p53 correlates with failure to imatinib response in chronic myeloid leukemia. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2013, Volume: 67, Issue:2 Topics: Adult; Alleles; Antineoplastic Agents; Arginine; Benzamides; Codon; Female; Genetic Predisposition to Disease; Genotype; Heterozygote; Homozygote; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Polymorphism, Genetic; Proline; Pyrimidines; Tumor Suppressor Protein p53	2013
Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition. Proceedings of the National Academy of Sciences of the United States of America, 2009, Mar-10, Volume: 106, Issue:10 Topics: Arginine; ATP Binding Cassette Transporter, Subfamily B, Member 2; ATP-Binding Cassette Transporters; Cell Separation; Circular Dichroism; Crystallography, X-Ray; Epitopes; HLA-A2 Antigen; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Minor Histocompatibility Antigens; Polymorphism, Genetic; Proteasome Endopeptidase Complex; Protein Binding; Protein Stability; Protein Structure, Secondary; Protein Transport; Receptors, Antigen, T-Cell; Surface Plasmon Resonance; T-Lymphocytes, Cytotoxic; Tissue Donors	2009
A single nucleotide polymorphism in the coding region of ABL and its effects on sensitivity to imatinib. Leukemia, 2005, Volume: 19, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Alleles; Antineoplastic Agents; Arginine; Benzamides; Blood Donors; Case-Control Studies; Drug Resistance, Neoplasm; Female; Genes, abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Polymorphism, Single Nucleotide; Pyrimidines	2005
Apaf1 in chronic myelogenous leukemia (CML) progression: reduced Apaf1 expression is correlated with a H179R p53 mutation during clinical blast crisis. Cell cycle (Georgetown, Tex.), 2007, Mar-01, Volume: 6, Issue:5 Topics: Apoptotic Protease-Activating Factor 1; Arginine; Blast Crisis; Gene Expression Regulation, Leukemic; Histidine; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Point Mutation; Tumor Suppressor Protein p53	2007
Arginine butyrate downregulates p210 bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cells. Leukemia, 1998, Volume: 12, Issue:6 Topics: Antineoplastic Agents; Apoptosis; Arginine; Butyrates; Down-Regulation; Fusion Proteins, bcr-abl; Humans; Janus Kinase 1; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Protein-Tyrosine Kinases; Tumor Cells, Cultured	1998
The effect of topoisomerase inhibitors on the expression of differentiation markers and cell cycle progression in human K-562 leukemia cells. Experimental cell research, 1992, Volume: 203, Issue:1 Topics: Amsacrine; Aphidicolin; Cell Cycle; Cell Differentiation; Cycloheximide; Deoxyadenosines; Dose-Response Relationship, Drug; Etoposide; G2 Phase; Hemoglobins; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanins; Mitosis; Novobiocin; Teniposide; Topoisomerase II Inhibitors; Tumor Cells, Cultured	1992
Effective reinduction therapy for childhood acute nonlymphoid leukemia using simultaneous continuous infusions of teniposide and amsacrine. Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:2 Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukopenia; Male; Mouth Mucosa; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Stomatitis; Teniposide; Thrombocytopenia	1989